| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e44deeb5df1538ea99d84e92b9711371
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_284fb70291593c102b491a63c172815a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2019-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_204cfbca3244929d4ac14af09f3481a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a411a742f53f862c79519b9d1482461f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f45b10bcdee28622efed826342b62522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_db80a40e27041c209476649682467dac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0426fd524a47ed6336394fd2e6ea43bf |
| publicationDate |
2021-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112204051-A |
| titleOfInvention |
Antibody binding to AXL protein and its application |
| abstract |
A kind of described antibody or its antigen-binding fragment thereof is provided, and it possesses one or more properties selected from the following group: 1) can bind to AXL protein with a K D value of 1 × 10-8 M or lower; 2 ) can specifically recognize the AXL protein expressed on the cell surface; 3) can mediate internalization after binding to the AXL protein expressed on the cell surface. The antibodies can also be used to construct immunoconjugates. The antibodies and immunoconjugates can inhibit the proliferation of tumor cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113444180-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113444180-A |
| priorityDate |
2018-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |